This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Frank A. De Leon-Jones, MD; John M. Davis, MD; Edet E. Inwang, PhD; Haroutune Dekirmenjian

Arch Gen Psychiatry. 1983;40(8):841-847.

Abstract
• Catecholamine metabolites excreted by long-term methadone hydrochloride—dependent subjects were studied in a protocol involving a two-study design. After a two-week methadone maintenance period, 15 subjects underwent abrupt methadone withdrawal and 12 subjects, gradual methadone withdrawal. The first study compared levels of catecholamine metabolites excreted during the stable methadone period with those excreted during the abrupt withdrawal period, as well as with those eliminated by healthy nonaddicted controls. No changes in the excretion of 3-methoxy-4-hydroxyphenylglycol and normetanephrine were noted between the methadone maintenance period and the time of abrupt methadone with drawal. These values did not differ from those obtained for controls. However, higher levels of metanephrine were excreted during the stable methadone period than those in controls. During withdrawal, levels of metanephrine dropped a statistically significant amount in comparison with levels observed during the stable methadone period. The gradual withdrawal study confirmed these findings.

Author Affiliations
From the Veterans Administration West Side Medical Center (Dr De Leon—Jones), Illinois State Psychiatric Institute (Dr Davis and Mr Dekirmenjian), and West Side Organization (Dr Inwang), Chicago.

Footnotes
Accepted for publication Feb 8, 1983.

Reprint requests to Veterans Administration West Side Medical Center, 820 S Damen Ave, Chicago, IL 60612 (Dr De Leon—Jones).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?